The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1972, 109: 275-283.
Copyright © 1972 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jerry, L. M.
Right arrow Articles by Adams, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jerry, L. M.
Right arrow Articles by Adams, L.

Stabilization of Dissociable IgA2 Proteins by Secretory Component

L. M. Jerry1, H. G. Kunkel and L. Adams

From the Rockefeller University, New York, New York 10021

Abstract

The Am2(+) genetic variant of human IgA2 immunoglobulins is potentially unstable because it lacks disulfide bridges between the heavy (H) and light (L) chains. It dissociates spontaneously under denaturing conditions into heavy and light chain dimer subunits (H2, L2), without the need for prior reduction. Isolated secretory component (SC) binds to human Am2(+), IgA2 myeloma proteins in vitro, and stabilizes them so that they will no longer dissociate into subunits in the presence of denaturants. Both human and bovine SC will bind to and stabilize the polymer forms of these myeloma proteins, but only human SC will bind to and stabilize monomeric proteins. The reaction involves the whole IgA2 molecule rather than just its subunits. Moreover, SC will stabilize a pepsin F(ab')2 fragment. Since stabilization is prevented by iodoacetic acid, covalent disulfide bonding appears to be involved. The ability of SC to stabilize the potentially dissociable Am2(+) genetic variant of IgA2 may enhance its capacity to function in external secretions.

Footnotes

1 Present address: Division of Immunochemistry and Allergy, Royal Victoria Hospital, Montreal, Canada.




This article has been cited by other articles:


Home page
J. Exp. Med.Home page
L. Erlandsson, P. Akerblad, C. Vingsbo-Lundberg, E. Kallberg, N. Lycke, and T. Leanderson
Joining Chain-expressing and -nonexpressing B Cell Populations in the Mouse
J. Exp. Med., August 27, 2001; 194(5): 557 - 570.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Lycke, L. Erlandsson, L. Ekman, K. Schon, and T. Leanderson
Lack of J Chain Inhibits the Transport of Gut IgA and Abrogates the Development of Intestinal Antitoxic Protection
J. Immunol., July 15, 1999; 163(2): 913 - 919.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.